Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Quattro74on Jul 30, 2020 12:16pm
145 Views
Post# 31344333

RE:Tactical blunders

RE:Tactical blunders
1357councilrock wrote: Despite infuriating tactical blunders the science continues prove itself. Roswell addition adds weight to that argument and should help eliminate some of the ineptness that dogs the current leadership. Another plus is the adding of power and experience in a very important market.

Believe it or not TLT is entering a new phase underpinned by a science proving itself at a ridiculously slow pace. IMO this is about to change.






I think that these mistakes were perhaps spurred by the Covid mess. And these mistakes were made by world class PDT Docs like Lilge. So I doubt once the Covid 19 mess cools down that these Docs will have the same problems moving forward. Like Macer said, more fine tuning. I don't neccesarily blame 'Management', who have also been impacted by Covid 19.

<< Previous
Bullboard Posts
Next >>